Maternal Sirolimus Therapy for Fetal Cardiac Rhabdomyomas

N Engl J Med. 2018 May 10;378(19):1844-1845. doi: 10.1056/NEJMc1800352.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Oral
  • Antibiotics, Antineoplastic / therapeutic use*
  • Disease Progression
  • Echocardiography
  • Female
  • Fetal Diseases / drug therapy*
  • Fetal Heart / diagnostic imaging
  • Heart Neoplasms / drug therapy*
  • Heart Neoplasms / genetics
  • Humans
  • Infant
  • Pregnancy
  • Rhabdomyoma / drug therapy*
  • Rhabdomyoma / genetics
  • Sirolimus / therapeutic use*
  • TOR Serine-Threonine Kinases / antagonists & inhibitors
  • Ultrasonography, Prenatal

Substances

  • Antibiotics, Antineoplastic
  • TOR Serine-Threonine Kinases
  • Sirolimus